Literature DB >> 31216050

T cell functionality in HIV-1, HIV-2 and dually infected individuals: correlates of disease progression and immune restoration.

S Salwe1, V Padwal1, V Nagar2, P Patil2, V Patel1.   

Abstract

The role of suppressive anti-retroviral therapy (ART) in eliciting restoration of dysregulated immune function remains unclear in HIV-1 infection. Also, due to tailoring of therapeutic regimens towards HIV-1, this possible impairment of therapy may be even more pronounced in HIV-2 and dual (HIV-D) infection. Thus, we evaluated the impact of ART on immune restoration by assessing T cell functions, including HIV specific responses in HIV-1-, HIV-2- and HIV-D-infected individuals. Both ART-treated and naive infected subjects showed persistently altered frequency of CD4+ T cell subsets [regulatory T cells (Treg ), naive/central memory, effector memory], increased immune activation, cytoxicity and decreased frequency of natural killer T (NKT)- like cells and T helper type 17 (Th17)/Treg ratio with elevated microbial translocation. Further, HIV-specific responses were dominated by gag-specific CD4+ T cells in virologically suppressed HIV-D individuals, suggesting retention of T cell memory for both viruses. Increased antigen-specific responses, including dual-functional interleukin (IL)-2/interferon (IFN)-γ CD4+ T cells, were detected in therapy receiving HIV-2-infected individuals indicative of a greater and more functionally diverse T cell memory repertoire. We delineated immune signatures specific to therapy-naive single HIV infection, as well as a unique signature associated with HIV-2 disease progression and immune restoration. Circulating Treg frequency, T cell activation and microbial translocation levels correlated with disease progression and immune restoration among all types of HIV infection. Also, memory responses negatively correlated, irrespective of type of infection, in ART receiving infected individuals, with CD4 rebound and decreased pan T cell activation. Our data highlight the need for adjunct immunomodulatory therapeutic strategies to achieve optimal immune restoration in HIV infection.
© 2019 British Society for Immunology.

Entities:  

Keywords:  HIV-2 infection; HIV-specific responses; anti-retroviral therapy; disease progression; dual (HIV-D) infection; immune restoration

Year:  2019        PMID: 31216050      PMCID: PMC6797902          DOI: 10.1111/cei.13342

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

1.  Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2.

Authors:  Markus Moll; Jennifer Snyder-Cappione; Gerald Spotts; Frederick M Hecht; Johan K Sandberg; Douglas F Nixon
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

2.  Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.

Authors:  J P Casazza; M R Betts; L J Picker; R A Koup
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 3.  Granzyme B in injury, inflammation, and repair.

Authors:  Paul R Hiebert; David J Granville
Journal:  Trends Mol Med       Date:  2012-10-22       Impact factor: 11.951

4.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

Authors:  Yves Levy; Christine Lacabaratz; Laurence Weiss; Jean-Paul Viard; Cecile Goujard; Jean-Daniel Lelièvre; François Boué; Jean-Michel Molina; Christine Rouzioux; Véronique Avettand-Fénoêl; Thérèse Croughs; Stéphanie Beq; Rodolphe Thiébaut; Geneviève Chêne; Michel Morre; Jean-François Delfraissy
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

5.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

6.  Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire.

Authors:  Stéphania Koblavi-Dème; Luc Kestens; Debra Hanson; Ronald A Otten; Marie-Yolande Borget; Célestin Bilé; Stefan Z Wiktor; Thierry H Roels; Terence Chorba; John N Nkengasong
Journal:  AIDS       Date:  2004-02-20       Impact factor: 4.177

7.  Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

Authors:  Stephen A Migueles; Christine M Osborne; Cassandra Royce; Alex A Compton; Rohan P Joshi; Kristin A Weeks; Julia E Rood; Amy M Berkley; Jonah B Sacha; Nancy A Cogliano-Shutta; Margaret Lloyd; Gregg Roby; Richard Kwan; Mary McLaughlin; Sara Stallings; Catherine Rehm; Marie A O'Shea; JoAnn Mican; Beverly Z Packard; Akira Komoriya; Sarah Palmer; Ann P Wiegand; Frank Maldarelli; John M Coffin; John W Mellors; Claire W Hallahan; Dean A Follman; Mark Connors
Journal:  Immunity       Date:  2008-12-08       Impact factor: 31.745

Review 8.  Can early therapy reduce inflammation?

Authors:  Netanya G Sandler; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

Review 9.  Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?

Authors:  N Kumarasamy; Atul Patel; Sanjay Pujari
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

10.  Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P Moss; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; A Hurley; M Markowitz; D D Ho; A J McMichael; D F Nixon
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  4 in total

1.  sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.

Authors:  Dhanashree Jagtap; Vikrant M Bhor; Shilpa Bhowmick; Nandini Kasarpalkar; Pooja Sagvekar; Bhalchandra Kulkarni; Manish Pathak; Nirjhar Chatterjee; Pranam Dolas; Harsha Palav; Snehal Kaginkar; Sharad Bhagat; Itti Munshi; Swapneil Parikh; Sachee Agrawal; Chandrakant Pawar; Mala Kaneria; Smita D Mahale; Jayanthi Shastri; Vainav Patel
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

2.  Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4+ T Cells in the Pathogenesis of HIV-2 Infection and Disease Progression.

Authors:  Sivasankaran Munusamy Ponnan; K K Vidyavijayan; Kannan Thiruvengadam; Nancy Hilda J; Manikannan Mathayan; Kailapuri Gangatharan Murugavel; Luke Elizabeth Hanna
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

3.  Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.

Authors:  Varsha M Prabhu; Amit Kumar Singh; Varsha Padwal; Vidya Nagar; Priya Patil; Vainav Patel
Journal:  Front Immunol       Date:  2019-12-06       Impact factor: 7.561

4.  Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection.

Authors:  Amit Kumar Singh; Sukeshani Salwe; Varsha Padwal; Shilpa Velhal; Jyoti Sutar; Shilpa Bhowmick; Srabani Mukherjee; Vidya Nagar; Priya Patil; Vainav Patel
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.